---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004715"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-02-03T23:59:59+00:00"
generated_at: "2026-05-27T04:26:45.416699+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences closes ~$5M public offering of stock and warrants

## Summary
- Gross proceeds ~$5M, net ~$4.3M from sale of 1.67M shares/pre-funded, Series A & B warrants at $3.00/unit.
- Series A warrants (5-yr, $3.00 strike) and Series B warrants (18-mo, $3.00 strike) are exercisable immediately.
- Proceeds earmarked for EB-003 development, working capital, and general corporate purposes.
- H.C. Wainwright acted as placement agent, receiving 7% cash fee plus warrants to purchase 116,666 shares at $3.75.
- Offering closed on February 3, 2025, with pre-funded warrants exercisable at $0.0001 per share.

## SEC filing metadata
- accession: 0001493152-25-004715
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315225004715/0001493152-25-004715-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315225004715/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004715
- JSON: https://secwatch.observer/filing/0001493152-25-004715.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004715.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.